The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease

The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease

Monika Katko,1 Erika Galgoczi,1 Annamaria Erdei,1 Annamaria Gazdag,1 Eszter Berta,1 Miklos Bodor,1 Ildiko Seres,2 Ildiko Hircsu,1 Arpad Badics,1 Bernadett Ujhelyi,3 Livia Sira,1 Harjit Pal Bhattoa,4 Endre V Nagy1 1Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, Unive...

Full description

Bibliographic Details
Main Authors: Katko M, Galgoczi E, Erdei A, Gazdag A, Berta E, Bodor M, Seres I, Hircsu I, Badics A, Ujhelyi B, Sira L, Bhattoa HP, Nagy EV
Format: Article
Language:English
Published: Dove Medical Press 2021-05-01
Series:Journal of Inflammation Research
Subjects:
thyroid eye disease
graves’ disease
pai-1
4g/5g polymorphism
risk factor
Online Access:https://www.dovepress.com/the-4g5g-polymorphism-of-plasminogen-activator-inhibitor-type-1-is-a-p-peer-reviewed-fulltext-article-JIR

Similar Items

Similar Items